Alternatives to Aiomics

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

AI-powered platform accelerating biological research and drug discovery.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-powered platform for designing novel molecular structures for new medicines.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Life science company pioneering drug discovery with AI and advanced technologies.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.